study
-
Biologics
Early data demonstrate motor function improvement for spinal cord stem cell treatment
26th January 2017 A new therapy to treat spinal cord injuries in people who have lost all motor and sensory…
Read More » -
Biologics
InVivo Therapeutics Announces Sixth Patient Conversion in The INSPIRE Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)– InVivo Therapeutics Holdings Corp. (NVIV) today announced that the patient enrolled in December in the INSPIRE study of…
Read More » -
Spine
SI-BONE’s iFuse Implant System® Requires Revision Surgery 5 Times Less Compared to SI Joint Fixation with Screws According to New Peer-Reviewed Clinical Publication
SAN JOSE, Calif., Jan. 23, 2017 /PRNewswire/ — SI-BONE, Inc., an innovative medical device company that pioneered the use of the iFuse…
Read More » -
Biologics
InVivo Therapeutics Announces New Patient Enrollment into the INSPIRE Study
December 20, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that a new patient with a T8-9 fracture dislocation…
Read More » -
Biologics
Centrexion Therapeutics Announces Highly Statistically Significant Topline Results from Phase 2b Study of CNTX-4975 in Patients with Knee Osteoarthritis Pain
Boston – December 13, 2016 – Centrexion Therapeutics, a company focused on advancing the treatment of chronic pain with one of the largest…
Read More » -
Financial
JOT Study Finds Generic Orthopaedic Implants Clinically Equivalent and Provide High Value
December 01, 2016 RENO, Nev.–(BUSINESS WIRE)–The Orthopaedic Implant Company (OIC), a medical device company that specializes in high-value orthopaedic implants,…
Read More » -
Sports Medicine
Moximed: First Patient Treated in US Study of Atlas® System for Unicompartmental Knee Osteoarthritis
November 29, 2016 HAYWARD, Calif.–(BUSINESS WIRE)–Moximed®, Inc. announced today that the first patient has been treated in an FDA-approved IDE…
Read More » -
Extremities
Now Enrolling Patients for a Research Study Examining the Feasibility of Treating Osteoarthritic Knee with Autologous Bone Marrow Concentrate
CHICAGO, ILLINOIS (PRWEB) NOVEMBER 25, 2016 This study is a prospective, open label, non-randomized study to be conducted at the…
Read More » -
Spine
Minimus Spine Enrolls 30th Subject to Randomized Study Comparing Triojection® to Discectomy
November 14, 2016 Minimus Spine, the developer and manufacturer of the Triojection System, a novel system intended to facilitate the…
Read More » -
Extremities
Osteoarthritis: New blood test detects early stages, study finds
28 October 2016 – Written by Catharine Paddock PhD There is currently no blood test for early-stage osteoarthritis, a degenerative joint…
Read More » -
Biologics
AMNIOX Highlights Study Demonstrating Improved Outcomes in Patients Treated with CLARIX® Regenerative Matrix as an Adjunct to Lumbar Discectomy
October 26, 2016 ATLANTA–(BUSINESS WIRE)–AMNIOX Medical, Inc., a TissueTech™, Inc., company, announced the results of a prospective randomized clinical study…
Read More » -
Biologics
Orthocell Receives Approval for Human Nerve Regeneration Study Using CelGro®
October 17, 2016 PERTH, Australia–(BUSINESS WIRE)–Regenerative medicine company Orthocell has been granted ethics approval for a human study examining the…
Read More » -
Biologics
InVivo Therapeutics Announces Foothills Medical Centre in Calgary, Alberta as New Canadian Site for INSPIRE Study
October 19, 2016 CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that the Foothills Medical Centre in Calgary, Alberta has…
Read More »